treatment of hepatitis c virus infections with telaprevir (vx-950) in patients unresponsive to treatment with pegylated interferon alfa-2a / 2b and ribavirin

• 收藏
• 分享

专利权人:

VERTEX PHARMACEUTICALS INCORPORATED

发明人:

Ira Jacobson,John Mchutchison,Lindsay Mcnair

申请号：

BRPI0911673

公开号：

BRPI0911673A2

申请日:

2009.04.23

申请国别(地区):

BR

年份:

2017

代理人:

摘要：

The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/